443642-29-3
443642-29-3
Chemical Structure
MK-0608
- CAS No.: 443642-29-3
- Formula:C12H16N4O4
- Molecular Weight:280.28
IUPAC Name: (2R,3R,4R,5R)-2-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol
InChIKey: IRZRJANZDIOOIF-GAJNKVMBSA-N
SMILES: OC[C@@H]1[C@@H](O)[C@](O)(C)[C@H](N2C=CC3=C2N=CN=C3N)O1
Biological Activity: MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MK-0608 | 99.81% | MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MK-0608 (Standard) | ≥98% | MK-0608 (Standard) is the analytical standard of MK-0608 (HY-10244). This product is intended for research and analytical applications. MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
